Retatrutide 20mg

Retatrutide 20mg – Research Use Only

Product Overview:
Retatrutide is an investigational peptide known as a triple receptor agonist for GIP, GLP-1, and glucagon receptors. This broad receptor activity has made it a subject of interest in advanced metabolic and endocrine research.

Research Background:

Preclinical and early clinical studies indicate Retatrutide may deliver greater weight reduction outcomes compared to dual agonists.

Research suggests potential benefits in glucose metabolism, insulin sensitivity, and lipid regulation.

Investigated for its effects on appetite control, energy expenditure, and obesity-related pathways.

Key Research Benefits:

Supports studies in multi-receptor metabolic regulation

Valuable for obesity and type 2 diabetes research models

Useful for exploring hormonal pathways affecting appetite and energy balance

Contributes to research on insulin and lipid metabolism

Product Format:

Supplied in sterile 3ml clinical-grade vial

20mg concentration

Professionally packaged with NI Peptides pharmaceutical-style labeling

Important Notice:

All NI Peptides products are provided strictly for laboratory research purposes only.

Not for human consumption

Not for medical, veterinary, or household use